O-1 Visa Medical Devices Business Funding

O-1 medical device innovators — engineers with cleared or approved devices, inventors whose patents have advanced diagnostic or therapeutic capability, and medtech entrepreneurs whose work has received significant industry recognition — build businesses with real revenue from device sales, hospital contracts, and distribution agreements. Bankable funds O-1 medical device businesses on device sales and distribution revenue — not immigration status. Check your Bankability Score.

What Medical Device Funding Covers

• Manufacturing scale-up: Production tooling, contract manufacturing agreements
• FDA 510(k) and PMA costs: Regulatory clearance expenses
• Sales team expansion: Hospital and clinic sales representatives
• Distribution agreements: Distributor onboarding, stocking programs
• Clinical evidence: Post-market clinical study costs
• Working capital: Bridging hospital net-30/60/90 payment terms

Hospital and Group Purchasing Organization Revenue

Medical devices sold through hospitals and GPOs generate large, net-60 to net-90 payment cycles. A device company billing $150,000/month to hospital accounts carries $100,000-$300,000 in outstanding receivables at any time. Bankable advances capital against this receivables base, enabling the company to continue growing without waiting for hospital accounts to clear. Hospital and GPO payment is reliable — Bankable's underwriting accounts for the cycle, not just the delay.

Non-Dilutive Bridge to Commercial Milestones

Between FDA clearance and breakeven sales volume, medical device companies often need $500K-$3M in bridge capital. Venture capital requires proof of sales velocity that may not yet exist; traditional loans require collateral that a startup may not have. Bankable evaluates the revenue that already exists — even early sales — alongside the strength of the product's market position and regulatory status.